+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Interventional Oncology Market by Product (Ablation Devices, Embolization Devices, Supportive Devices), Cancer Type (Colorectal Cancer, Kidney Cancer, Liver Cancer), Technology, End-User - Global Forecast 2025-2030- Product Image
Interventional Oncology Market by Product (Ablation Devices, Embolization Devices, Supportive Devices), Cancer Type (Colorectal Cancer, Kidney Cancer, Liver Cancer), Technology, End-User - Global Forecast 2025-2030- Product Image
Sale

Interventional Oncology Market by Product (Ablation Devices, Embolization Devices, Supportive Devices), Cancer Type (Colorectal Cancer, Kidney Cancer, Liver Cancer), Technology, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 4905026
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Interventional Oncology Market grew from USD 2.55 billion in 2024 to USD 2.73 billion in 2025. It is expected to continue growing at a CAGR of 7.39%, reaching USD 3.92 billion by 2030.

Interventional oncology represents a significant leap forward in the treatment of cancer, blending precision technology with minimally invasive techniques. As traditional cancer treatments evolve, this field has emerged as a vital complement to standard oncological procedures. The evolving landscape of interventional oncology not only reflects a broader shift towards patient-centric care, but it also indicates how advanced imaging and real-time guidance are reshaping the way clinicians approach tumor ablation and embolization.

The convergence of research and clinical practice has accelerated innovation and set new benchmarks for safety and efficacy. This introduction outlines the journey undertaken by the industry, emphasizing the integration of technological advancements with clinical protocols. The narrative highlights the drive behind the increased adoption of interventional oncology techniques in cancer treatment strategies, underscoring the balance between minimally invasive procedures and enhanced diagnostic precision.

As the sector expands its footprint, the interplay of emerging technologies and improved device functionalities paves the way for a future where personalized cancer treatment transforms patient outcomes. This evolving environment demands that decision-makers and experts continuously refresh their industry knowledge to keep pace with these groundbreaking changes.

Transformative Shifts in the Landscape

Over recent years, the interventional oncology landscape has undergone transformational shifts that have redefined market dynamics and clinical practices. Advancements in device functionalities, coupled with emerging technologies, have set the stage for novel approaches in cancer treatment. The transition from conventional procedures to minimally invasive techniques is bolstered by significant improvements in imaging, precision targeting, and real-time monitoring of therapeutic interventions.

The evolution within this niche is driven by a confluence of factors, including enhanced clinical outcomes, accelerated treatment cycles, and the demand for improved patient quality of life. One of the most notable trends is the integration of digital innovations and artificial intelligence, which are poised to further streamline procedure planning and execution. As clinical data increasingly supports the benefits of rapid, targeted treatments, healthcare providers are investing in the latest technology to deliver state-of-the-art patient care.

This period of change is marked by a shift towards multifunctional devices that not only increase treatment efficacy but also minimize recovery times. In essence, these transformative shifts are redefining established treatment paradigms, rendering interventional oncology a focal point for industry innovators and clinical experts alike.

Key Segmentation Insights

An in-depth analysis of the interventional oncology market reveals comprehensive insights driven by multifaceted segmentation. Under the product category, the market is studied across ablation devices, embolization devices, and supportive devices. Ablation devices, for instance, are systematically examined by splitting them into cryoablation devices and high-intensity focused ultrasound, catering to varying clinical needs. In parallel, embolization devices are dissected into drug-eluting beads and microspheres, while supportive devices are evaluated by their guidewires and introduction kits functionalities.

The segmentation based on cancer type includes examinations in colorectal cancer, kidney cancer, liver cancer, and lung cancer. This approach allows for a precise understanding of disease prevalence and treatment response variability, lending insights into market demand and clinical efficiencies. Similarly, technological segmentation, encompassing brachytherapy, image-guided radiotherapy, microwave ablation, and radiofrequency ablation, highlights the differences in mechanism of action and therapeutic outcomes, fueling innovation and market penetration.

When analyzing the end-user segment, the market is scrutinized through a focus on ambulatory surgical centers, cancer research institutes, and hospitals. Each category reflects distinct decision-making processes and varied adoption rates influenced by clinical service requirements. This holistic segmentation not only supports tailored market strategies but also guides industry stakeholders through the intricate layers of evolving therapeutic modalities and adoption trends in interventional oncology.

Based on Product, market is studied across Ablation Devices, Embolization Devices, and Supportive Devices. The Ablation Devices is further studied across Cryoablation Devices and High-Intensity Focused Ultrasound. The Embolization Devices is further studied across Drug-Eluting Beads and Microspheres. The Supportive Devices is further studied across Guidewires and Introduction Kits.

Based on Cancer Type, market is studied across Colorectal Cancer, Kidney Cancer, Liver Cancer, and Lung Cancer.

Based on Technology, market is studied across Brachytherapy, Image-Guided Radiotherapy, Microwave Ablation, and Radiofrequency Ablation.

Based on End-User, market is studied across Ambulatory Surgical Centers, Cancer Research Institutes, and Hospitals.

Key Regional Insights

Regional analysis of the interventional oncology market uncovers critical variations in adoption patterns, regulatory environments, and healthcare infrastructure. Insights drawn from the Americas indicate a robust market driven by high patient awareness, widespread adoption of advanced medical devices, and a mature healthcare system that rapidly integrates cutting-edge medical technologies. The narrative from the Americas lays a foundation for understanding how market dynamics are influenced by a strong network of clinical research institutions and a proactive approach to patient care.

The narrative extends to Europe, Middle East, and Africa, where healthcare policies and varying levels of infrastructure influence market penetration. In these regions, the blend of legacy clinical practices with emerging minimally invasive therapies creates a diverse landscape. Meanwhile, Asia-Pacific reveals a burgeoning demand for innovative interventional oncology procedures due to rapidly expanding healthcare investments and increasing access to advanced technological solutions. This section emphasizes that each of these regions has its distinctive challenges and opportunities that shape market strategies and influence growth trajectories.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Innovation

A closer look at the competitive landscape within interventional oncology identifies numerous key players whose innovations are setting industry benchmarks. Among these, companies such as Abbott Laboratories and Accuray Incorporated have been instrumental in integrating advanced imaging with precision therapy. Notably, organizations like Alpinion Medical Systems Co., Ltd. and AngioDynamics, Inc. continue to expand their portfolios with novel device technologies.

Market leaders including Atricure, Inc. and BALT Group, along with global powerhouses such as Bayer AG and Boston Scientific Corporation, have consistently pushed the boundaries of device technological integration. Firms like Cook Group Incorporated, Eckert & Ziegler BEBIG AG, and Fujifilm Holdings Corporation have also contributed substantially to the enhancement of device performance and patient safety. Other influential names include GE Healthcare, Hologic, Inc., and IceCure Medical Ltd. Their commitment to innovation is further evidenced by the significant investments made by Integer Holding Corporation and Johnson & Johnson Services, Inc.

The influence of companies such as Koninklijke Philips N.V., Medtronic PLC, and Merit Medical Systems in shaping clinical outcomes is noticeable. Firms like Profound Medical Corp. and Siemens Healthineers provide the backbone of technological innovation, complementing the efforts of Sirtex Medical Limited, Sonablate Corp, and Stryker Corporation. This intense competition is complemented by strategic moves from Teleflex Incorporated and Terumo Corporation, ensuring that the market continues to evolve at a rapid pace with an uncompromising focus on therapeutic excellence.

The report delves into recent significant developments in the Interventional Oncology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accuray Incorporated, Alpinion Medical Systems Co., Ltd., AngioDynamics, Inc., Atricure, Inc., BALT Group, Bayer AG, Boston Scientific Corporation, Cook Group Incorporated, Eckert & Ziegler BEBIG AG, Fujifilm Holdings Corporation, GE Healthcare, Hologic, Inc., IceCure Medical Ltd., Integer Holding Corporation, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Medtronic PLC, Merit Medical Systems, Profound Medical Corp., Siemens Healthineers, Sirtex Medical Limited, Sonablate Corp, Stryker Corporation, Teleflex Incorporated, and Terumo Corporation.

Actionable Recommendations for Industry Leaders

Industry leaders must harness the current transformative tides within interventional oncology to secure competitive advantages in the market. It is imperative to invest in research and development that bridges the gap between technological innovation and clinical application. Leaders should collaborate closely with academic institutions and clinical experts to accelerate the adoption of emerging techniques and validate the efficacy of newly integrated devices.

To drive sustainable growth, organizations are encouraged to adopt a data-driven approach by leveraging advanced analytics and real-world evidence. Continuous monitoring of treatment outcomes, patient feedback, and market trends will help refine product offerings and operational strategies. Moreover, strategic alliances with technology providers and other key stakeholders can foster an integrated ecosystem that facilitates knowledge sharing and innovation.

Furthermore, it is essential to align organizational objectives with dynamic regulatory frameworks and market demands. Leaders should focus on streamlining internal processes, ensuring rigorous quality control, and engaging in proactive communication with regulatory bodies. This will not only accelerate device approvals but also enhance confidence among end-users. Ultimately, the recommendation is clear: a balanced investment in innovation, collaboration, and market intelligence is fundamental to propelling interventional oncology toward a new era of therapeutic precision and improved patient outcomes.

The interventional oncology market is rapidly evolving, propelled by technological breakthroughs and a growing demand for minimally invasive procedures. The comprehensive insights across product, cancer type, technology, and end-user segments underscore the multifactorial dynamics that shape this vibrant sector. The regional analyses further illuminate how diverse healthcare ecosystems worldwide adapt and adopt new innovations to meet regional challenges.

Leading companies continue to set high benchmarks with continuous innovation, and their strategic maneuvers promise sustained market growth. In parallel, the actionable recommendations outlined resonate strongly with industry leaders, emphasizing a path where collaborative efforts and targeted investments will deepen clinical adoption and improve overall patient care. The future of interventional oncology is indeed promising, with these integrated strategies laying the groundwork for long-term success in an increasingly competitive landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of cancer globally
5.1.1.2. Rising awareness and acceptance of interventional oncology as a treatment option among patients and providers
5.1.1.3. Increasing healthcare expenditure and investments in interventional oncology worldwide
5.1.2. Restraints
5.1.2.1. High costs associated with interventional oncology procedures
5.1.3. Opportunities
5.1.3.1. Integration of artificial intelligence in optimizing workflow and diagnosis in interventional oncology
5.1.3.2. Advancements in cryoablation technology for minimally invasive cancer treatments
5.1.4. Challenges
5.1.4.1. Addressing concerns about the clinical efficacy and safety of emerging interventional oncology
5.2. Market Segmentation Analysis
5.2.1. Product: Rising significance of ablation devices owing to their minimally invasive nature and effectiveness in tumour destruction
5.2.2. End-User: Expanding adoption of interventional oncology among ambulatory surgical centers
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Interventional Oncology Market, by Product
6.1. Introduction
6.2. Ablation Devices
6.2.1. Cryoablation Devices
6.2.2. High-Intensity Focused Ultrasound
6.3. Embolization Devices
6.3.1. Drug-Eluting Beads
6.3.2. Microspheres
6.4. Supportive Devices
6.4.1. Guidewires
6.4.2. Introduction Kits
7. Interventional Oncology Market, by Cancer Type
7.1. Introduction
7.2. Colorectal Cancer
7.3. Kidney Cancer
7.4. Liver Cancer
7.5. Lung Cancer
8. Interventional Oncology Market, by Technology
8.1. Introduction
8.2. Brachytherapy
8.3. Image-Guided Radiotherapy
8.4. Microwave Ablation
8.5. Radiofrequency Ablation
9. Interventional Oncology Market, by End-User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Cancer Research Institutes
9.4. Hospitals
10. Americas Interventional Oncology Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Interventional Oncology Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Interventional Oncology Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2024
13.2. FPNV Positioning Matrix, 2024
13.3. Competitive Scenario Analysis
13.3.1. Delcath Systems secures USD 16.3 million through warrant exercises to advance liver cancer treatment strategies
13.3.2. Boston Scientific expands interventional oncology offerings with acquisition of Intera Oncology Inc to enhance liver cancer treatments
13.3.3. Varian secures FDA clearance for IntelliBlate microwave ablation ecosystem
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. INTERVENTIONAL ONCOLOGY MARKET MULTI-CURRENCY
FIGURE 2. INTERVENTIONAL ONCOLOGY MARKET MULTI-LANGUAGE
FIGURE 3. INTERVENTIONAL ONCOLOGY MARKET RESEARCH PROCESS
FIGURE 4. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 9. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 11. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 13. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 15. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 17. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 19. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 25. INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. INTERVENTIONAL ONCOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. INTERVENTIONAL ONCOLOGY MARKET DYNAMICS
TABLE 7. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CRYOABLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY DRUG-ELUTING BEADS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY INTRODUCTION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY IMAGE-GUIDED RADIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 58. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 59. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 60. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 61. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 65. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 66. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 67. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 95. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 96. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 97. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 98. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 102. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 103. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 104. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 105. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 116. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 117. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 118. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 119. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 120. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 158. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 159. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 160. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 161. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 178. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 180. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 181. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 182. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 183. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 187. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 188. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 189. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 190. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 194. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 195. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 196. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 197. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 198. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 201. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 202. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 203. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 204. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 207. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 208. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 209. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 210. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 211. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 222. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 223. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 224. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 225. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 226. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 241. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 242. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 243. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 244. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 245. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 246. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 247. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 248. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 249. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 250. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 251. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 252. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 253. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 255. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 256. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 257. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 258. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 259. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 260. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 283. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 284. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 285. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 286. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 287. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 288. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 289. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 290. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 304. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 305. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 306. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 307. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 308. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 309. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 310. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 318. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
TABLE 320. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 324. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 325. INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2024
TABLE 326. INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

  • Abbott Laboratories
  • Accuray Incorporated
  • Alpinion Medical Systems Co., Ltd.
  • AngioDynamics, Inc.
  • Atricure, Inc.
  • BALT Group
  • Bayer AG
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Eckert & Ziegler BEBIG AG
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Hologic, Inc.
  • IceCure Medical Ltd.
  • Integer Holding Corporation
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Merit Medical Systems
  • Profound Medical Corp.
  • Siemens Healthineers
  • Sirtex Medical Limited
  • Sonablate Corp
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedMarch 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.73 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.92 Billion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Interventional Oncology Market Size, Share & Trends Analysis Report By Technique (Ablation Therapies, Embolization Therapies), By Procedure (Tumor Ablation, Tumor Biopsy), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Interventional Oncology Market Size, Share & Trends Analysis Report By Technique (Ablation Therapies, Embolization Therapies), By Procedure (Tumor Ablation, Tumor Biopsy), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 210 Pages
  • Global
From
Interventional Oncology Market by Devices & Consumables (RF, Microwave, Cryoablation. Embolization), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung), End User (Hospital, Specialty Clinic) - Global Forecast to 2029 - Product Image

Interventional Oncology Market by Devices & Consumables (RF, Microwave, Cryoablation. Embolization), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung), End User (Hospital, Specialty Clinic) - Global Forecast to 2029

  • Report
  • 456 Pages
  • Global
From
Interventional Oncology Ablation Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Interventional Oncology Ablation Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Interventional Oncology Devices Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Interventional Oncology Devices Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 157 Pages
  • Global
From
Interventional Oncology Devices - Global Strategic Business Report - Product Image

Interventional Oncology Devices - Global Strategic Business Report

  • Report
  • 92 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.